Fundraising FoxMunich · Pre-Seed–Series A · 5 people tracked
Find your way into CARMA FUND
627 people in our graph share verified history with the CARMA FUND team — schools, employers, funds. One of them is your warm intro.
Investment thesis
CARMA FUND I invests in early-stage Life Science and Healthcare ventures across Europe, offering long investment horizons and flexible investment modes suited to specialist biotech and medical development timelines. Leveraging close ties with leading technology transfer offices and industry partners, the fund supports young companies and projects from initial development toward market entry. It targets therapeutics, diagnostics, medtech, and digital health, and remains open to related areas such as R&D tools, platform technologies, and healthcare-system improvements. The fund positions itself as an active partner in advancing therapeutic and medical innovation for patient benefit.
Source: firm website, verified Sep 27, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 11 of 18 portfolio companiesDigital Health ×8Biotech ×7Medical Devices ×7AI & Machine Learning ×6Healthtech ×5Deep Tech ×3Data & Infrastructure ×1Longevity ×1
HQs:Germany×7
Investments · 18 tracked
founders shown can be your intro pathAcorai develops a non-invasive, handheld heart monitor that estimates cardiac and pulmonary pressures (including PCWP and RAP) and hemodynamic congestion trends to help clinicians manage and personalize heart failure therapy.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsCapital Q® Ventures Inc.Creative Destruction Lab (CDL)Meridian Health Ventures
Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams.
AI & Machine LearningBiotechDigital HealthBerlin, DE
Co-investorsBoehringer Ingelheim Venture FundHTGFIBB VenturesMayo Clinic Ventures
Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders.
AI & Machine LearningDeep TechHealthtechMedical Devices
Matthias Puls(CEO)inBrian Blischak(President)in
Co-investorsHeal CapitalTruVenturo GmbH468 CapitalHTGF
Elkedonia is a biotech company developing a novel antidepressant treatment that targets intracellular neuroplasticity pathways rather than synaptic mechanisms, with the goal of providing rapid, long-lasting relief for depression patients.
BiotechDigital HealthMental Health
Delphine Charvin(Founding Chief Executive Officer & Board Director)inMélanie Rouillier(VP, Chief Operations Officer & Co-Founder)inJocelyne Caboche(President of the Scientific Advisory Board & Co-Founder)in
Co-investorsAngelini VenturesKurma PartnersSambrinvest
A company bringing together expertise in genetics, pathology, medicine, and bioinformatics to develop data science and AI solutions in the healthcare field.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesHeidelberg, DE
David Jones(Chief Scientific Officer & Co-founder)Natalie JägerinMartin Sill(Head of Data Science & Co-founder)inFelix SahmDaniel Schrimpf(Head of Software Development & Co-founder)inAreeba Patelin
Co-investorsLBBW Venture Capital GmbHHTGF
Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.
BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE
Hans Moebius(Co-founder and CMO, Head of Clinical Operations)inAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in
Co-investorsAndera PartnersFountain Healthcare PartnersGimvLBBW Venture Capital GmbHLifeArc VenturesModi Ventures
Genome Biologics operates a contract research service using TrueCardium, an iPSC-derived multicellular human cardiac organoid platform, to run cardiotoxicity screening, disease modeling, and drug efficacy studies.
BiotechDeep TechHealthtech
inContAlert is a medical technology startup developing a non-invasive wearable sensor that measures bladder fill level and uses machine learning to alert incontinence patients via an app when they should empty their bladder.
AI & Machine LearningDigital HealthMedical Devices
JannikTristanNicolasPascal
Co-investorsBayern KapitalSpinLab
Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases.
AI & Machine LearningBiotechMedical DevicesSchönefeld, DE
Johanna Holldack(CEO)in
BoardPierre Morgon(Chairman)Wolfram Nothaft(Deputy Chairman)
Co-investorsBrandenburg KapitalRemiges Ventures, Inc.Ventura BioMed Investors
Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMunich, DE
BoardChristian Leikert(Managing Partner)inDr. Martin Raditsch(Managing Partner)in
Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Friedrich Lämmel(CEO)inJohn Trimpop(CTO)Paul Burggraf(COO)in
Co-investorsKickstart InnovationAbstract VenturesDarling VenturesJoyance PartnersOpenspace VenturesShanda Group+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AkribionAllogeneticsDimericon TherapeuticsSalvina TherapeuticsSympheraTECregenWMT
Portfolio news
latest coverage across their companiesAignostics · prnewswire.com · Sep 12, 2026
Elkedonia · finsmes.com · Jun 11, 2025
Frequently asked questions
- How many investments has CARMA FUND made?
- CARMA FUND has 18 tracked investments.
- What stage does CARMA FUND invest at?
- CARMA FUND invests at the Pre-Seed, Seed, Series A stages.
- What sectors does CARMA FUND focus on?
- CARMA FUND focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is CARMA FUND located?
- CARMA FUND is headquartered in Munich, DE.
- Who does CARMA FUND co-invest with?
- CARMA FUND most often shares deals with BioMedPartners, Bayern Kapital, Brandenburg Kapital, among 16 tracked co-investors.
Images
.jpg)
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
InnoCom Bio Equities manages life science special purpose vehicles, offering investors a diversified portfolio of innovative life sciences technologies and providing seed capital to innovators and founders.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.